Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome

Br J Nutr. 2012 May;107(10):1429-34. doi: 10.1017/S0007114511004491. Epub 2011 Sep 14.

Abstract

The aim of the present study was to investigate the effects of Bifidobacterium adolescentis (Bif) supplementation on visceral fat accumulation and insulin sensitivity of the metabolic syndrome in HF-diet-fed rats. Adult male Wistar rats (n 10 per group) were fed four different experimental diets for 12 weeks as follows: standard diet; high-fat (HF) diet; a mix of HF diet and Bif; a mix of standard diet and Bif. Liver, mesenteric fat, epididymal fat, retroperitoneal fat, and inguinal fat, pancreas and triceps surae in all four groups of the rats were weighed, while liver steatosis and insulin sensitivity were evaluated at the end point of the study. As the number of intestinal Bifidobacterium species decreased obviously, fat pad weight and body weight increased significantly in the HF group compared with in the other three groups (P <0·05). Addition of Bif led to a reduction in body weight and fat pad weight (P <0·05). With an increase in liver weight, more severe steatosis of hepatocytes was observed in the HF group compared with in the other three groups. A significant decrease of the glucose infusion rate and pancreas weight was found in the HF group (P <0·05). This deleterious effect was alleviated when Bif was added to the diets. Bifidobacterium supplementation ameliorated visceral fat accumulation and insulin sensitivity of the metabolic syndrome in HF-diet-fed rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / drug effects
  • Animals
  • Bifidobacterium*
  • Body Weight / drug effects*
  • Diet / adverse effects
  • Dietary Fats / adverse effects
  • Dietary Supplements*
  • Disease Models, Animal
  • Fatty Liver / metabolism
  • Fatty Liver / prevention & control
  • Glucose / metabolism
  • Hepatocytes / drug effects
  • Hepatocytes / pathology
  • Insulin Resistance
  • Intra-Abdominal Fat / drug effects*
  • Intra-Abdominal Fat / metabolism
  • Liver / drug effects
  • Male
  • Metabolic Syndrome / metabolism
  • Metabolic Syndrome / pathology
  • Metabolic Syndrome / prevention & control*
  • Obesity, Abdominal / etiology
  • Obesity, Abdominal / prevention & control*
  • Organ Size
  • Pancreas / drug effects
  • Probiotics / therapeutic use*
  • Rats
  • Rats, Wistar

Substances

  • Dietary Fats
  • Glucose